Leslie A. Bruch

A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors

Leslie A. Bruch, Debbie Hill, Dan X. Cai et al. · Human Pathology · 2001 · 100 citations

Life Sciences, Genetics, Oncology +14

Identification of a Novel, Recurrent <scp>SLC44A1‐PRKCA</scp> Fusion in Papillary Glioneuronal Tumor

Julia A. Bridge, Xiao‐qiong Liu, János Sümegi et al. · Brain Pathology · 2012 · 76 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study

Robert S. Bridge, Julia A. Bridge, James R. Neff et al. · Journal of Clinical Pathology · 2004 · 74 citations · Full text

Life Sciences, Genetics, Oncology +16

Competency assessment of residents in surgical pathology using virtual microscopy

Leslie A. Bruch, Barry R. De Young, Clarence D. Kreiter et al. · Human Pathology · 2009 · 70 citations

Medicine, Medical Education, Pathology +16

Chromosome 22q dosage in composite extrarenal rhabdoid tumors: Clonal evolution or a phenotypic mimic?

Christine Fuller, John D. Pfeifer, Peter A. Humphrey et al. · Human Pathology · 2001 · 58 citations

Life Sciences, Genetics, Oncology +12